SCHEMBL13309406

SCHEMBL13309406

CC(C)(C)OC(=O)N1CCCC(c2cc(N(C(=O)OC(C)(C)C)c3ccc(-n4ccnc4)cc3)n3ncc(Br)c3n2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 7/20 0.44
▸ PIK3CD O00329 1/20 0.41
▸ TRPV3 Q8NET8 1/20 0.35
▸ FPR2 P25090 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ PDE2A O00408 1/20 0.33
▸ HPGDS O60760 1/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CCND2 P30279 1/20 0.32
▸ CCND3 P30281 1/20 0.32
▸ PRMT5 O14744 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13309405 0.88 PIK3CD (0.41) GPR119PIK3CD
SCHEMBL13309478 0.84 GPR119 (0.44) GPR119PIK3CDTRPV3FPR2CYP2C9
SCHEMBL14519195 0.83 TRPV3 (0.37) TRPV3FPR2HPGDSJAK2PRMT5
SCHEMBL14561897 0.79 TRPV3 (0.36) PIK3CDTRPV3FPR2HPGDSJAK2
SCHEMBL14561898 0.78 ALDH1A1 (0.37) GPR119TRPV3HPGDSMEN1ALDH1A1
SCHEMBL13309134 0.76 TRPV3 (0.39) TRPV3FPR2HPGDSJAK2MEN1
SCHEMBL14541613 0.75 TRPV3 (0.43) PIK3CDTRPV3FPR2HPGDSJAK2
SCHEMBL14942244 0.75 CHEK1 (0.53) TRPV3FPR2HPGDSJAK2JAK1
SCHEMBL11931323 0.75 TRPV3 (0.43) TRPV3FPR2CYP2C9HPGDSJAK2
SCHEMBL11931324 0.74 TRPV3 (0.42) TRPV3FPR2CYP2C9HPGDSJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934224-B1 PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS FOR THE TREATMENT OF CANCER SCHERING CORP (US) 2010-06-09 — — EP disclosed
US-7205308-B2 Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors SCHERING CORPORATION (US) 2007-04-17 — — US disclosed
Send feedback